Randomized Controlled Trial of the Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

被引：0
|
作者：
Gogenur, Mikail [1 ]
Gogenur, Ismail [1 ]
机构：
[1] Zealand Univ Hosp, Ctr Surg Sci, Dept Surg, Roskilde, Denmark
来源：
ANNALS OF SURGERY | 2017年 / 266卷 / 06期
关键词：
OPEN SURGERY; ANESTHESIA; REDUCTION; MORTALITY;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E105 / E106
页数：2
相关论文
共 50 条
  • [11] Adjuvant Chemotherapy for Stage III Colon Cancer
    Taieb, Julien
    Gallois, Claire
    CANCERS, 2020, 12 (09) : 1 - 17
  • [12] Efficacy and safety of mFOLFOX6 with apatinib as postoperative adjuvant chemotherapy in stage IIIB or IIIC colorectal cancer
    Gu, Xiaodong
    Zhou, Minwei
    Wang, Zihao
    Li, Zhenyang
    Yang, Yi
    Zang, Yiwen
    Zhou, Yiming
    Xiang, Jianbin
    Chen, Zongyou
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [13] A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
    Wolmark, N.
    Yothers, G.
    O'Connell, M. J.
    Sharif, S.
    Atkins, J. N.
    Seay, T. E.
    Feherenbacher, L.
    O'Reilly, S.
    Allegra, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [14] A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
    Wolmark, N.
    Yothers, G.
    O'Connell, M. J.
    Sharif, S.
    Atkins, J. N.
    Seay, T. E.
    Feherenbacher, L.
    O'Reilly, S.
    Allegra, C. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [15] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [16] Adjuvant Chemotherapy for Stage II Colon Cancer
    Rebuzzi, Sara Elena
    Pesola, Guido
    Martelli, Valentino
    Sobrero, Alberto Felice
    CANCERS, 2020, 12 (09) : 1 - 12
  • [17] A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy
    Kazuhiko Yoshimatsu
    Keiichiro Ishibashi
    Keiji Koda
    Hajime Yokomizo
    Noritaka Oda
    Mitsuru Oshiro
    Hiroyuki Kato
    Masatoshi Oya
    Hideo Nakajima
    Shinji Ooki
    Hiroshi Maekawa
    Toshio Matsunami
    Masahiro Tsubaki
    Takeshi Yamada
    Michiya Kobayashi
    Kohji Tanakaya
    Masaru Yokoyama
    Hideyuki Ishida
    Surgery Today, 2019, 49 : 498 - 506
  • [18] A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy
    Yoshimatsu, Kazuhiko
    Ishibashi, Keiichiro
    Koda, Keiji
    Yokomizo, Hajime
    Oda, Noritaka
    Oshiro, Mitsuru
    Kato, Hiroyuki
    Oya, Masatoshi
    Nakajima, Hideo
    Ooki, Shinji
    Maekawa, Hiroshi
    Matsunami, Toshio
    Tsubaki, Masahiro
    Yamada, Takeshi
    Kobayashi, Michiya
    Tanakaya, Kohji
    Yokoyama, Masaru
    Ishida, Hideyuki
    SURGERY TODAY, 2019, 49 (06) : 498 - 506
  • [19] Adjuvant chemotherapy for stage III colon cancer patients
    Balakrishnan, L
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1496 - 1496
  • [20] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
    Ramos-Esquivel, Allan
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 395 - 395
12345